Literature DB >> 24219278

The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.

Leah C Young1, Michael J Hendzel.   

Abstract

The Jumonji D2 proteins (JMJD2/KDM4) function to demethylate di- and trimethylated (me2/3) histone 3 lysine 9 (H3K9me2/3) and H3K36me3. Knockout mouse models for Kdm4b and Kdm4d have not resulted in gross abnormalities, while mouse models for Kdm4a and Kdm4c have not been reported. However, the KDM4 subfamily of demethylases are overexpressed in several tumor types. Overexpression of KDM4 proteins alters transcription and chromatin remodeling, driving cellular proliferation, anchorage-independent growth, invasion, and migration. Increased proliferation occurs through KDM4-mediated modification of cell cycle timing, as well as through increased numbers of replication forks. Recent evidence also suggests that KDM4C overexpression contributes to the maintenance of a pluripotent state. Together these data suggest that overexpression of KDM4 proteins induces numerous oncogenic effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 24219278     DOI: 10.1139/bcb-2012-0054

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  36 in total

1.  JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.

Authors:  Xudong Shen; Zhixiang Zhuang; Yusong Zhang; Zhigang Chen; Liqin Shen; Wangyang Pu; Lei Chen; Zhonghua Xu
Journal:  Tumour Biol       Date:  2015-04-16

2.  Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.

Authors:  Roselyne M Labbé; Andreana Holowatyj; Zeng-Quan Yang
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

3.  GPS2/KDM4A pioneering activity regulates promoter-specific recruitment of PPARγ.

Authors:  M Dafne Cardamone; Bogdan Tanasa; Michelle Chan; Carly T Cederquist; Jaclyn Andricovich; Michael G Rosenfeld; Valentina Perissi
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

4.  Genome-wide Kdm4 histone demethylase transcriptional regulation in Drosophila.

Authors:  Amy Tsurumi; Shuang Xue; Lin Zhang; Jinghong Li; Willis X Li
Journal:  Mol Genet Genomics       Date:  2019-04-24       Impact factor: 3.291

5.  Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models.

Authors:  Young K Chen; Tiziana Bonaldi; Alessandro Cuomo; Joselyn R Del Rosario; David J Hosfield; Toufike Kanouni; Shih-Chu Kao; Chon Lai; Neethan A Lobo; Jennifer Matuszkiewicz; Andrew McGeehan; Shawn M O'Connell; Lihong Shi; Jeffrey A Stafford; Ryan K Stansfield; James M Veal; Michael S Weiss; Natalie Y Yuen; Michael B Wallace
Journal:  ACS Med Chem Lett       Date:  2017-07-27       Impact factor: 4.345

6.  Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.

Authors:  Luma Dayane de Carvalho Filiú-Braga; Teresa Raquel Tavares Serejo; Antonio Roberto Lucena-Araujo; Francisco Assis Rocha Neves; Juliana Lott de Carvalho; Eduardo Magalhaes Rego; Felipe Saldanha-Araujo
Journal:  Med Oncol       Date:  2018-11-13       Impact factor: 3.064

Review 7.  Histone methylations in heart development, congenital and adult heart diseases.

Authors:  Qing-Jun Zhang; Zhi-Ping Liu
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

8.  Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.

Authors:  Leah C Young; Darin W McDonald; Michael J Hendzel
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

9.  KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes.

Authors:  Lingling Duan; Ganesha Rai; Carlos Roggero; Qing-Jun Zhang; Qun Wei; Shi Hong Ma; Yunyun Zhou; John Santoyo; Elisabeth D Martinez; Guanghua Xiao; Ganesh V Raj; Ajit Jadhav; Anton Simeonov; David J Maloney; Josep Rizo; Jer-Tsong Hsieh; Zhi-Ping Liu
Journal:  Chem Biol       Date:  2015-09-10

10.  KDM4B promotes DNA damage response via STAT3 signaling and is a target of CREB in colorectal cancer cells.

Authors:  Wei-Wu Deng; Qian Hu; Zheng-Ren Liu; Qiu-Hong Chen; Wen-Xiang Wang; Huai-Gen Zhang; Qin Zhang; Yuan-Lu Huang; Xue-Kang Zhang
Journal:  Mol Cell Biochem       Date:  2018-04-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.